litlas
Log inCreate account

Mark H. Stoler

Active 1983–2025

Also published as
Mark H Stoler
132
Papers
24,233
Citations
83
h-index
128
i10-index

Citations

Citations per year for Mark H. Stoler1986: 1 citations1987: 9 citations1988: 18 citations1989: 21 citations1990: 24 citations1991: 26 citations1992: 32 citations1993: 24 citations1994: 25 citations1995: 33 citations1996: 49 citations1997: 59 citations1998: 78 citations1999: 64 citations2000: 78 citations2001: 88 citations2002: 164 citations2003: 107 citations2004: 109 citations2005: 126 citations2006: 169 citations2007: 181 citations2008: 136 citations2009: 138 citations2010: 131 citations2011: 115 citations2012: 206 citations2013: 167 citations2014: 126 citations2015: 181 citations2016: 142 citations2017: 110 citations2018: 96 citations2019: 529 citations2020: 544 citations2021: 454 citations2022: 367 citations2023: 278 citations2024: 408 citations2025: 223 citations2026: 3 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,290 citing papers, 31.1% of this breakdownUnited Kingdom: 486 citing papers, 6.6% of this breakdownChina: 470 citing papers, 6.4% of this breakdownGermany: 319 citing papers, 4.3% of this breakdownCanada: 287 citing papers, 3.9% of this breakdownFrance: 278 citing papers, 3.8% of this breakdownItaly: 251 citing papers, 3.4% of this breakdownNetherlands: 238 citing papers, 3.2% of this breakdownAustralia: 191 citing papers, 2.6% of this breakdownSpain: 169 citing papers, 2.3% of this breakdownBelgium: 163 citing papers, 2.2% of this breakdownJapan: 153 citing papers, 2.1% of this breakdown
0%31.1%Other 28.1%

Institutions

Fields

  • Medicine77.4%
  • Biochemistry, Genetics and Molecular Biology9.3%
  • Immunology and Microbiology7.3%
  • Neuroscience1.8%
  • Computer Science1.7%
  • Engineering0.3%
  • Other2.2%

Topics

  • Cervical Cancer and HPV Research17.9%
  • Endometrial and Cervical Cancer Treatments4.1%
  • Genital Health and Disease3.8%
  • Head and Neck Cancer Studies3.5%
  • Hepatitis B Virus Studies3%
  • Reproductive tract infections research3%
  • Other64.7%

Coauthors

All papers

Open in search
  1. The Biology and Life-Cycle of Human Papillomaviruses

    Authors: John Doorbar, Wim Quint, Lawrence Banks, Ignacio G. Bravo, Mark H. Stoler, Tom R. Broker, Margaret Stanley - Vaccine 2012 cited by 1,503

  2. Final efficacy, immunogenicity, and safety analyses of a nine-valent human papillomavirus vaccine in women aged 16–26 years: a randomised, double-blind trial

    Authors: Warner K. Huh, Elmar A. Joura, Anna R. Giuliano, Ole-Erik Iversen, Rosíres Pereira de Andrade, Kevin A. Ault, Deborah Bartholomew, Ramón M. Cestero, Edison Natal Fedrizzi, Angelica Lindén Hirschberg, Marie‐Hélène Mayrand, Ángela María Ruiz-Sternberg, Jack T. Stapleton, Dorothy J. Wiley, Alex Ferenczy, Robert J. Kurman, Brigitte M. Ronnett, Mark H. Stoler, Jack Cuzick, Suzanne M. Garland, Susanne K. Kjær, Oliver Bautista, Richard M. Haupt, Erin Moeller, Michael Ritter, Christine C. Roberts, Christine Shields, Alain Luxembourg - The Lancet 2017 cited by 459

  3. The Lower Anogenital Squamous Terminology Standardization Project for HPV-Associated Lesions: Background and Consensus Recommendations from the College of American Pathologists and the American Society for Colposcopy and Cervical Pathology

    Authors: Teresa M. Darragh, Terence J. Colgan, J. Thomas Cox, Debra S. Heller, Michael Henry, Ronald D. Luff, Timothy H. McCalmont, Ritu Nayar, Joel M. Palefsky, Mark H. Stoler, Edward J. Wilkinson, Richard J. Zaino, David C. Wilbur, David C. Wilbur, Teresa M. Darragh, Michael Henry, Timothy H. McCalmont, Ronald D. Luff, Edward J. Wilkinson, J. Thomas Cox, Edward J. Wilkinson, Dennis M. O’Connor, R. Kevin Reynolds, M. Angélica Selim, James Scurry, Michael Henry, David Chelmow, Lydia Howell, Brigitte M. Ronnett, Alan G. Waxman, Timothy H. McCalmont, Hope K. Haefner, Kieron Leslie, Christopher M. Shea, Paul N. Staats, Joel M. Palefsky, Alice Lytwyn, Barbara Winkler, Jennifer M. Roberts, Terence J. Colgan, Levi S. Downs, Rodolfo Laucirica, Richard J. Zaino, Debra S. Heller, Jill Allbritton, Olga B. Ioffe, Nancy E. Joste, Teresa M. Darragh, J. Michael Berry, Oscar Lin, Mark L. Welton, Christopher N. Otis, David C. Wilbur, Mark H. Stoler, Joel S. Bentz, Christina S. Kong, Bradley J. Quade, Mary R. Schwartz, Ronald D. Luff, Ritu Nayar, Philip E. Castle, Máire A. Duggan, Francisco García, Ann Moriarty, Greg Niedt, Alicia Carter, Marc T. Goodman, Margaret B. Neal, Vijaya Reddy, Stanley J. Robboy, Mona Saraiya, Steven M. Silverberg, Susan E. Spires - Archives of Pathology & Laboratory Medicine 2012 cited by 1,001

  4. HPV Vaccine against Anal HPV Infection and Anal Intraepithelial Neoplasia

    Authors: Joel M. Palefsky, Anna R. Giuliano, Stephen E. Goldstone, Edson Duarte Moreira, Carlos Aranda, Heiko Jessen, Richard J. Hillman, Daron Ferris, François Coutlée, Mark H. Stoler, J. Brooke Marshall, David Radley, Scott Vuocolo, Richard M. Haupt, Dalya Güriş, Elizabeth Garner - New England Journal of Medicine 2011 cited by 938

  5. Efficacy of the bivalent HPV vaccine against HPV 16/18-associated precancer: long-term follow-up results from the Costa Rica Vaccine Trial

    Authors: Carolina Porras, Sabrina H. Tsang, Rolando Herrero, Diego Guillén, Teresa M. Darragh, Mark H. Stoler, Allan Hildesheim, Sarah Wagner, Joseph F. Boland, Douglas R. Lowy, John T. Schiller, Mark Schiffman, John Schussler, Mitchell H. Gail, Wim Quint, Rebeca Ocampo, Jorge Morales, Ana Cecilia Rodríguez, Shangying Hu, Joshua N. Sampson, Aimée R. Kreimer, Bernal Cortés, Paula González, Rolando Herrero, Silvia E. Jiménez, Carolina Porras, Ana Cecilia Rodríguez, Allan Hildesheim, Aimée R. Kreimer, Douglas R. Lowy, Mark Schiffman, John T. Schiller, Mark E. Sherman, Lígia A. Pinto, Troy J. Kemp, Mary Sidawy, Wim Quint, Leen‐Jan van Doorn, Linda Struijk, Joel M. Palefsky, Teresa M. Darragh, Mark H. Stoler - The Lancet Oncology 2020 cited by 130

  6. Precancerous cervical lesions caused by non-vaccine-preventable HPV types after vaccination with the bivalent AS04-adjuvanted HPV vaccine: an analysis of the long-term follow-up study from the randomised Costa Rica HPV Vaccine Trial

    Authors: Jaimie Z. Shing, Shangying Hu, Rolando Herrero, Allan Hildesheim, Carolina Porras, Joshua N. Sampson, John Schussler, John T. Schiller, Douglas R. Lowy, Mónica S. Sierra, Loretto J Carvajal, Aimée R. Kreimer, Bernal Cortés, Paula González, Rolando Herrero, Silvia E. Jiménez, Carolina Porras, Ana Cecilia Rodríguez, Allan Hildesheim, Aimée R. Kreimer, Douglas R. Lowy, Mark Schiffman, John T. Schiller, Mark E. Sherman, Sholom Wacholder, Lígia A. Pinto, Troy J. Kemp, Mary Sidawy, Wim Quint, Leen‐Jan van Doorn, Linda Struijk, Joel M. Palefsky, Teresa M. Darragh, Mark H. Stoler - The Lancet Oncology 2022 cited by 52

  7. Primary cervical cancer screening with human papillomavirus: End of study results from the ATHENA study using HPV as the first-line screening test

    Authors: Thomas C. Wright, Mark H. Stoler, Catherine Behrens, Abha Sharma, Guili Zhang, Teresa L. Wright - Gynecologic Oncology 2015 cited by 584

  8. Efficacy, immunogenicity, and safety of a quadrivalent HPV vaccine in men: results of an open-label, long-term extension of a randomised, placebo-controlled, phase 3 trial

    Authors: Stephen E Goldstone, Anna R Giuliano, Joel M Palefsky, Eduardo Lazcano-Ponce, Mary E Penny, Robinson E Cabello, Edson D Moreira, Ezio Baraldi, Heiko Jessen, Alex Ferenczy, Robert Kurman, Brigitte M Ronnett, Mark H Stoler, Oliver Bautista, Rituparna Das, Thomas Group, Alain Luxembourg, Hao Jin Zhou, Alfred Saah - The Lancet Infectious Diseases 2021 cited by 104

  9. Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial

    Authors: Luisa L. Villa, Ronaldo Lúcio Rangel Costa, Carlos Alberto Petta, Rosíres Pereira de Andrade, Kevin A. Ault, Anna R. Giuliano, Cosette M. Wheeler, Laura A. Koutsky, Christian Malm, Matti Lehtinen, Finn Egil Skjeldestad, Sven-Eric Olsson, Margareta Steinwall, Darron R. Brown, Robert J. Kurman, Brigitte M. Ronnett, Mark H. Stoler, Alex Ferenczy, Diane M. Harper, Gretchen Tamms, Jimmy Yu, Lisa Lupinacci, Radha Railkar, Frank J. Taddeo, Kathrin U. Jansen, Mark T. Esser, Heather L. Sings, Alfred J. Saah, Eliav Barr - The Lancet Oncology 2005 cited by 1,580

  10. Nine-valent HPV vaccine efficacy against related diseases and definitive therapy: comparison with historic placebo population

    Authors: Anna R. Giuliano, Elmar A. Joura, Suzanne M. Garland, Warner K. Huh, Ole-Erik Iversen, Susanne K. Kjær, Alex Ferenczy, Robert J. Kurman, Brigitte M. Ronnett, Mark H. Stoler, Oliver Bautista, Erin Moeller, Michael Ritter, Christine Shields, Alain Luxembourg - Gynecologic Oncology 2019 cited by 94

  11. Interobserver Reproducibility of Cervical Cytologic and Histologic InterpretationsRealistic Estimates From the ASCUS-LSIL Triage Study

    Authors: Mark H. Stoler - JAMA 2001 cited by 1,077

  12. Clinical validation of p16/Ki‐67 dual‐stained cytology triage of HPV‐positive women: Results from the IMPACT trial

    Authors: Thomas C. Wright, Mark H. Stoler, Jim Ranger‐Moore, Qijun Fang, Patrick Volkir, Mahboobeh Safaeian, Ruediger Ridder - International Journal of Cancer 2021 cited by 66

  13. Analysis of Ugandan cervical carcinomas identifies human papillomavirus clade–specific epigenome and transcriptome landscapes

    Authors: Alessia Gagliardi, Vanessa Porter, Zusheng Zong, Reanne Bowlby, Emma Titmuss, Constance Namirembe, Nicholas B. Griner, Hilary Petrello, Jay Bowen, Simon K. Chan, Luka Culibrk, Teresa M. Darragh, Mark H. Stoler, Thomas C. Wright, Patee Gesuwan, Maureen A. Dyer, Yussanne Ma, Karen Mungall, Steven J.M. Jones, Carolyn Nakisige, Karen Novik, Jackson Orem, Martin Origa, Julie M. Gastier‐Foster, Robert Yarchoan, Corey Casper, Gordon B. Mills, Janet S. Rader, Akinyemi I. Ojesina, Daniela S. Gerhard, Andrew J. Mungall, Marco A. Marra - Nature Genetics 2020 cited by 78

  14. The efficacy and safety of Tipapkinogen Sovacivec therapeutic HPV vaccine in cervical intraepithelial neoplasia grades 2 and 3: Randomized controlled phase II trial with 2.5 years of follow-up

    Authors: Diane M. Harper, Pekka Nieminen, Gilbert Donders, Mark H. Einstein, Francisco García, Warner K. Huh, Mark H. Stoler, Katerina Glavini, Gemma Attley, Jean‐Marc Limacher, Bérangère Bastien, Elizabeth Calleja - Gynecologic Oncology 2019 cited by 72

  15. Role of HPV Genotype, Multiple Infections, and Viral Load on the Risk of High-Grade Cervical Neoplasia

    Authors: Rachael Adcock, Jack Cuzick, William C. Hunt, Ruth McDonald, Cosette M. Wheeler, Nancy E. Joste, Walter Kinney, Cosette M. Wheeler, William C. Hunt, Ruth McDonald, Michael Robertson, Alan G. Waxman, Steven Jenison, Julia C. Gage, Philip E. Castle, Vicki B. Benard, Debbie Saslow, Jane J. Kim, Mark H. Stoler, Jack Cuzick, Giovanna Rossi Pressley, Kevin English - Cancer Epidemiology Biomarkers & Prevention 2019 cited by 125

  16. molBV reveals immune landscape of bacterial vaginosis and predicts human papillomavirus infection natural history

    Authors: Mykhaylo Usyk, Nicolas F. Schlecht, Sarah Pickering, LaShanda Williams, Christopher C. Sollecito, Ana Gradíssimo, Carolina Porras, Mahboobeh Safaeian, Lígia A. Pinto, Rolando Herrero, Howard D. Strickler, V. Shankar, Anne Nucci‐Sack, Ángela Díaz, Costa Rica HPV Vaccine Trial (CVT) Group, Bernal Cortés, Paula González, Silvia E. Jiménez, Ana Cecilia Rodríguez, Allan Hildesheim, Aimée R. Kreimer, Douglas R. Lowy, Mark Schiffman, John T. Schiller, Mark E. Sherman, Sholom Wacholder, Troy J. Kemp, Mary Sidawy, Wim Quint, Leen‐Jan van Doorn, Linda Struijk, Joel M. Palefsky, Teresa M. Darragh, Mark H. Stoler, Robert D. Burk - Nature Communications 2022 cited by 64

  17. The Lower Anogenital Squamous Terminology Standardization Project for HPV-Associated Lesions

    Authors: Teresa M. Darragh, Terence J. Colgan, J. Thomas Cox, Debra S. Heller, Michael Henry, Ronald D. Luff, Timothy H. McCalmont, Ritu Nayar, Joel M. Palefsky, Mark H. Stoler, Edward J. Wilkinson, Richard J. Zaino, David C. Wilbur - International Journal of Gynecological Pathology 2012 cited by 569

  18. Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older: a subanalysis of the ATHENA study

    Authors: Philip E. Castle, Mark H. Stoler, Thomas C. Wright, Abha Sharma, Teresa L. Wright, Catherine Behrens - The Lancet Oncology 2011 cited by 522

  19. Ten-Year Follow-up of 9-Valent Human Papillomavirus Vaccine: Immunogenicity, Effectiveness, and Safety

    Authors: Jaime Restrepo, Teobaldo Herrera, Rudiwilai Samakoses, Julio C. Reina, Punnee Pitisuttithum, Àngels Ulied, Linda‐Gail Bekker, Edson Duarte Moreira, Sven‐Eric Olsson, Stan L. Block, Luciano Serpa Hammes, Fábio Martins Laginha, Alex Ferenczy, Robert J. Kurman, Brigitte M. Ronnett, Mark H. Stoler, Oliver Bautista, Nancy Gallagher, Gino Salituro, Min Ye, Alain Luxembourg - PEDIATRICS 2023 cited by 46

  20. The ATHENA human papillomavirus study: design, methods, and baseline results

    Authors: Thomas C. Wright, Mark H. Stoler, Catherine Behrens, Raymond Apple, Toniann Derion, Teresa L. Wright - American Journal of Obstetrics and Gynecology 2011 cited by 280

  21. Effectiveness, immunogenicity, and safety of the quadrivalent HPV vaccine in women and men aged 27–45 years

    Authors: Ivette Maldonado, Manuel Plata, Mauricio González, Alfonso Correa, Claudia Nossa, Anna R. Giuliano, Elmar A. Joura, Alex Ferenczy, Brigitte M. Ronnett, Mark H. Stoler, Hao Zhou, Amita Joshi, Rituparna Das, Oliver Bautista, Thomas Group, Alain Luxembourg, Alfred J. Saah, Ulrike K. Buchwald - Human Vaccines & Immunotherapeutics 2022 cited by 36

  22. HER2 Overexpression and Amplification in Uterine Carcinosarcomas With Serous Morphology

    Authors: Taylor M. Jenkins, Leigh A. Cantrell, Mark H. Stoler, Anne M. Mills - The American Journal of Surgical Pathology 2022 cited by 30

  23. Triaging HPV-positive women with p16/Ki-67 dual-stained cytology: Results from a sub-study nested into the ATHENA trial

    Authors: Thomas C. Wright, Catherine Behrens, James Ranger‐Moore, Susanne Rehm, Abha Sharma, Mark H. Stoler, Ruediger Ridder - Gynecologic Oncology 2016 cited by 147

  24. A systematic review and meta-analysis on the attribution of human papillomavirus (HPV) in neuroendocrine cancers of the cervix

    Authors: Philip E. Castle, Amanda J. Pierz, Mark H. Stoler - Gynecologic Oncology 2017 cited by 130